These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 3963841

  • 1. [Elimination of suppressor macrophages in tumor-bearing mice by 6-mercaptopurine and its therapeutic contribution].
    Kataoka T.
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):701-5. PubMed ID: 3963841
    [Abstract] [Full Text] [Related]

  • 2. 6-Mercaptopurine-induced potentiation of active immunotherapy in L1210-bearing mice treated with concanavalin A-bound leukemia cell vaccine.
    Kataoka T, Akahori Y, Sakurai Y.
    Cancer Res; 1984 Feb; 44(2):519-24. PubMed ID: 6537896
    [Abstract] [Full Text] [Related]

  • 3. Mitomycin C-augmented production of I-A antigen-positive macrophages in tumor vaccine-primed mice.
    Kataoka T, Yamamoto T, Honjo K, Murayama T.
    Jpn J Cancer Res; 1986 Mar; 77(3):305-11. PubMed ID: 3009373
    [Abstract] [Full Text] [Related]

  • 4. Production of antitumor T-cells in tumor-bearing mice treated with tumor vaccine and 6-mercaptopurine.
    Kataoka T, Oh-hashi F.
    Cancer Res; 1985 Jul; 45(7):2962-6. PubMed ID: 3873988
    [Abstract] [Full Text] [Related]

  • 5. Suppressor macrophages in tumor-bearing mice and their selective inhibition by 6-mercaptopurine.
    Kataoka T, Oh-hashi F.
    Cancer Res; 1985 May; 45(5):2139-44. PubMed ID: 3157443
    [Abstract] [Full Text] [Related]

  • 6. Enhancement of the antitumor effect of 6-mercaptopurine by vitamin A.
    Akiyama S, Masuda A, Tabuki T, Kuwano M, Komiyama S.
    Gan; 1981 Oct; 72(5):742-6. PubMed ID: 7199007
    [Abstract] [Full Text] [Related]

  • 7. I-Ad antigen expression of pyran copolymer-induced peritoneal cells in tumor vaccine-primed mice and its association with the host antitumor response.
    Oh-hashi F, Kataoka T, Taniyama T.
    Cancer Immunol Immunother; 1987 Oct; 24(1):57-63. PubMed ID: 3102063
    [Abstract] [Full Text] [Related]

  • 8. In vivo potentiation of concanavalin A-bound L1210 vaccine by antimacrophage agents.
    Kataoka T, Oh-hashi F, Sakurai Y, Gomi K.
    Cancer Res; 1980 Oct; 40(10):3832-8. PubMed ID: 6254642
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Synergistic effects of bis(3-methylsulfonyloxypropyl)-amine toluenesulfonate (864-T) with 6-mercaptopurine and other antitumor agents.
    Imamura H, Ikegami K, Okumoto T.
    Gan; 1973 Oct; 64(5):427-31. PubMed ID: 4358730
    [No Abstract] [Full Text] [Related]

  • 14. Radiosensitivity of drug-resistant L1210 leukemia.
    Johnson RE.
    Cancer Res; 1967 Feb; 27(2):251-4. PubMed ID: 6018559
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evaluation of antileukemic agents in advanced leukemia L1210 in mice. IX.
    Kline I, Gang M, Tyrer DD, Venditti JM, Artis EW, Goldin A.
    Cancer Chemother Rep 2; 1971 Apr; 2(1):65-133. PubMed ID: 5565539
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Combined therapy of L1210 leukemia with cyclophosphamide and lycurim.
    Stoychkov JN, Milushev AS, Todorov DK.
    Neoplasma; 1980 Apr; 27(1):33-6. PubMed ID: 6892839
    [Abstract] [Full Text] [Related]

  • 19. Anti leukemia activity (L1210) of 6-mercaptopurine and its metallo complexes in mice.
    Skinner SM, Lewis RW.
    Res Commun Chem Pathol Pharmacol; 1977 Jan; 16(1):183-6. PubMed ID: 841179
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.